Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone

Metabolism: Clinical and Experimental

Volumn 56, Issue 1, 2007, Pages 24-29

  Osei, Kwame ^a   Gaillard, Trudy ^a   Schuster, Dara ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C PEPTIDE; GLUCOSE; INSULIN; ROSIGLITAZONE;

ADULT; AFRICAN AMERICAN; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MULTIPLE CYCLE TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER; LONGITUDINAL STUDIES; MIDDLE AGED; PILOT PROJECTS; THIAZOLIDINEDIONES;

EID: 33845194163     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.08.018     Document Type: Article

References (22)

1. Renynolds L.R., Konz E.C., Frederich R.G., and Anderson J.W. Rosiglitazone amplifies the benefits lifestyle intervention measures in long-term, type 2 diabetes mellitus. Diabetes Obes Metab 4 (2002) 270-275
2. Osei K., Rhinesmith S., Gaillard T., and Schuster D. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanism of action. Metabolism 52 (2003) 565-572
3. Osei K., Scott R., Gaillard T., Kaplow J., Bullock M., and Schuster D. Effects of rosiglitazone on plasma adiponectin, insulin sensitivity and insulin secretion in African Americans with impaired glucose tolerance and type 2 diabetes. Metabolism 53 (2004) 1552-1557
4. Buchanan T.A., Xiang A.H., Peters R.K., Kjos S.L., Marroquin A., Goico J., et al. Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women. Diabetes 51 (2002) 2796-2803
5. Schuster D., Gaillard T., Rhinesmith S., Habash D., and Osei K. The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. Metabolism 52 (2003) 1211-1217
6. Schuster D., Gaillard T., Rhinesmith S., Habash D., and Osei K. Impact of metformin on glucose metabolism in nondiabetic, obese African Americans: a placebo-controlled, 24-month randomized study. Diabetes Care 27 (2004) 2768-2769
7. Kim S.H., Abbasi F., Chu J.W., McLaughlin T.L., Lamanedoal C., Polonsky K.S., et al. Rosiglitazone reduces glucose stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin resistant individuals. Diabetes 54 (2005) 2447-2552
8. Osei K., and Schuster D.P. Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabet Med 11 (1994) 755-762
9. Arslanian S., and Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity in healthy blacks versus white adolescents. J Pediatr 129 (1996) 440-443
10. Goran M.I., Crutz M.L., Bergman R.N., and Watanabe R. Insulin resistance and associated compensatory responses in African American and Hispanic children. Diabetes Care 25 (2002) 2184-2190
11. Arslanian S.A., Saad R., Danadian K., and Janosky J. Hyperisnulinemia in African American children: decreased insulin clearance and increased secretion and its relationship to insulin sensitivity. Diabetes 51 (2002) 3014-3019
12. Jiang X., Srinivassan S.R., Dalferes E.R., and Berensen G.S. Racial (black-white) differences in insulin secretion an clearance in adolescents: the Bogalusa Heart Study. Pediatrics 134 (1996) 357-360
13. Osei K., and Holland G. Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients. Metabolism 36 (1987) 122-127
14. Bonora E., Zavaroni I., Bruschi F., Alpi O., Pezzarossa A., Guerra L., et al. Peripheral hyperinsulinemia of simple obesity, pancreatic hyper secretion or insulin impaired insulin metabolism. J Clin Endocrinol Metab 50 (1984) 1121-1127
15. Faber O.K., Christensen K., Kehlet H., Mabsbad S., and Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53 (1981) 8618-8621
16. Rossell R., Gomis R., Casamitjana R., Segura A.R., Viderdell E., and Rivera F.P. Reduced hepatic insulin extraction in obesity: relationship with peripheral insulin levels. J Clin Endocrinol Metab 56 (1983) 606-611
17. Meistas M.T., Margolis S., and Kowarski A.A. Hyperinsulinemia of obesity is due to decreased clearance of insulin. J Am Physiol 245 (1983) E155-E159
18. The Expert Committee on the Diagnosis of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
19. Polonsky K., and Rubenstein A.H. C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 33 (1984) 485-492
20. Mathews D.R., Hosker J.P., Rudenski A.S., Taylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program. Effects of lifestyle intervention and metformin. Diabetes 54 (2005) 2402-2414
22. Camastra S., Manco M., Mari A., Baldu S., Gastealdelli A., Greco A.V., et al. Beta cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 54 (2005) 2382-2389